Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 4
2016 4
2017 3
2018 1
2019 1
2020 3
2021 5
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Antitrypanosomal activity of new semi-synthetic bergenin derivatives.
El-Hawary SS, Mohammed R, AbouZid S, Zaki MA, Ali ZY, Elwekeel A, Elshemy HAH. El-Hawary SS, et al. Among authors: elshemy hah. Chem Biol Drug Des. 2022 Feb;99(2):179-186. doi: 10.1111/cbdd.14000. Epub 2021 Dec 29. Chem Biol Drug Des. 2022. PMID: 34967118
New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling.
Abdelgawad MA, Bukhari SNA, Musa A, Elmowafy M, Elkomy MH, Nayl AA, El-Ghorab AH, Alsohaimi IH, Abdel-Bakky MS, Althobaiti IO, Altaleb HA, Omar HA, Abdelazeem AH, Zaki MA, Shaker ME, Elshemy HAH. Abdelgawad MA, et al. Among authors: elshemy hah. Pharmaceuticals (Basel). 2022 Sep 10;15(9):1134. doi: 10.3390/ph15091134. Pharmaceuticals (Basel). 2022. PMID: 36145355 Free PMC article.
Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study.
Abdellatif KRA, Abdelall EKA, Elshemy HAH, Philoppes JN, Hassanein EHM, Kahk NM. Abdellatif KRA, et al. Among authors: elshemy hah. Bioorg Chem. 2022 Mar;120:105627. doi: 10.1016/j.bioorg.2022.105627. Epub 2022 Jan 19. Bioorg Chem. 2022. PMID: 35065465
Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA, Abdelall EKA, Elshemy HAH, Philoppes JN, Hassanein EHM, Kahk NM. Abdellatif KRA, et al. Among authors: elshemy hah. Bioorg Chem. 2021 Sep;114:105122. doi: 10.1016/j.bioorg.2021.105122. Epub 2021 Jun 25. Bioorg Chem. 2021. PMID: 34243075
Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction.
Abdelall EKA, A H Elshemy H, Labib MB, E A Mohamed F. Abdelall EKA, et al. Among authors: a h elshemy h. Bioorg Chem. 2022 Mar;120:105591. doi: 10.1016/j.bioorg.2021.105591. Epub 2021 Dec 31. Bioorg Chem. 2022. PMID: 34998122
21 results